GlassScriptPhysician profile
Tia Mccray
NPI 1104225135
$985.73
in general payments reported to CMS, 2019-2025
20 companies · $158 in 2025
The $158 reported for 2025 was more than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $275 · 2022: $409 · 2023: $49.20 · 2024: $95.58 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $302.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $219.43 | 2021-2025 | Slynd |
| Abbvie INC. | $110.23 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $80.15 | 2021 | |
| Myovant Sciences INC. | $77.56 | 2022 | |
| Shield Therapeutics INC | $49.90 | 2023-2025 | Accrufer |
| Organon LLC | $49.55 | 2021-2024 | |
| Sage Therapeutics, LLC | $45.05 | 2021-2022 | |
| Mylan Pharmaceuticals INC. | $41.69 | 2021-2022 | |
| Therapeuticsmd, INC. | $40.27 | 2021-2022 | |
| Coopersurgical, INC. | $39.25 | 2022-2025 | Paragard T 380a |
| Bayer Healthcare Pharmaceuticals INC. | $38.51 | 2022-2025 | |
| Evofem Biosciences, INC. | $31.07 | 2022 | |
| Sumitomo Pharma America, INC. | $27.33 | 2025 | Myfembree |
| Avion Pharmaceuticals | $25.24 | 2021-2022 | |
| Pfizer INC. | $24.08 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $21.94 | 2022 | |
| Merck Sharp & Dohme LLC | $20.82 | 2022 | |
| Scynexis, INC. | $16.66 | 2022 | |
| Hologic Sales and Service, LLC | $14.31 | 2024 | Aptima |
| Novo Nordisk INC | $12.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tia Mccray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.